Drugmaker to sell cheaper generic rival to EpiPen injectors

By Linda A. Johnson, The Associated Press
A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.
The penlike injectors are used to treat life-threatening allergic reactions. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.
Drugmaker Sandoz said Thursday the price of two generic injectors will be $250 without insurance. Two other generics on the market in the U.S. cost $30